HOYA Visiezorg, een leider in optische technologie-innovatie, deelde de resultaten van een driejarig follow-up klinisch onderzoek over zijn bekroondeMiYOSMARTde brillenlens met de gepatenteerde Defocus Incorporated Multiple Segments (D.I.M.S.) -technologie na de bekendmaking van de informatie op de recente conferentie van de European Academy of Optometry and Optics (EAOO).Denieuwe studie, gepubliceerd inMaart 2021in het British Journal of Ophthalmology, was conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University and follows-up on the two-year study which previously demonstrated evidence of the effectiveness of the lens in slowing down the progression of myopia in children ages 8-131.

De driejarige vervolgstudie, uitgevoerd bij 120 kinderen inAzië, included 65 from the original group using MiYOSMART lens who took part in the previous study and 55 children who moved from using a single-vision lens for two years to the MiYOSMART lens in the third yearAan het einde van het derde jaar, results in the original group of children using MiYOSMART lens showed that slowing in myopia progression over time was sustained and the group that moved from regular single-vision to MiYOSMART spectacle lens showed a significant and immediate slow-down in the progression of myopia.